Literature DB >> 2231266

In vivo and in vitro evidence for a common carrier mediated transport of choline and basic drugs through the blood-brain barrier.

Y S Kang1, T Terasaki, T Ohnishi, A Tsuji.   

Abstract

The blood-brain barrier (BBB) transport system for choline and basic drugs was characterized by the in vivo carotid artery injection technique (Oldendorf, Brain Res., 24, 372-376, 1970) and in vitro uptake into isolated bovine brain capillaries (Pardridge et al., J. Neurochem., 44, 1178-1184, 1985). Basic drugs such as eperisone, thiamine and scopolamine significantly inhibited choline uptake by the BBB with the half inhibitory concentration, IC50 value of 1.45, 2.06, and 0.47 mM, respectively. On the contrary, the uptake of choline was not inhibited by amino acids (L-phenylalanine and L-arginine) and acidic drugs (nicotinic acid, salicylic acid and valproic acid). Choline was taken up by the isolated brain capillaries in concentration and temperature dependent manners. The uptake of choline by the isolated bovine brain capillaries was significantly inhibited by eperisone, scopolamine and thiamine in consistent with the in vivo results. Furthermore, eperisone inhibited competitively the uptake of choline with the inhibition constant, Ki value of 455 microM. According to these results it was suggested that in the BBB choline and basic drugs would share a common carrier-mediated transport system.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2231266     DOI: 10.1248/bpb1978.13.353

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  4 in total

1.  Differential effect of CDP-choline on brain cytosolic choline levels in younger and older subjects as measured by proton magnetic resonance spectroscopy.

Authors:  S M Babb; K E Appelmans; P F Renshaw; R J Wurtman; B M Cohen
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

2.  Cation transport specificity at the blood-brain barrier.

Authors:  Paul R Lockman; James H McAfee; Werner J Geldenhuys; David D Allen
Journal:  Neurochem Res       Date:  2004-12       Impact factor: 3.996

3.  Carrier-mediated transport of H1-antagonist at the blood-brain barrier: a common transport system of H1-antagonists and lipophilic basic drugs.

Authors:  M Yamazaki; T Terasaki; K Yoshioka; O Nagata; H Kato; Y Ito; A Tsuji
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

Review 4.  Blood-brain barrier transport machineries and targeted therapy of brain diseases.

Authors:  Jaleh Barar; Mohammad A Rafi; Mohammad M Pourseif; Yadollah Omidi
Journal:  Bioimpacts       Date:  2016-12-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.